Spesolimab for a child with generalized pustular psoriasis accompanied epilepsy and hyperactivity

CONCLUSIONS: Spesolimab is effective in treating pediatric GPP patients, and it is potential to be a clinical treatment strategy for pediatric GPP in the future.

via https://pubmed.ncbi.nlm.nih.gov/40984684/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20251002010905&v=2.18.0.post9+e462414